Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Rhinoviruses (RVs), which are the most common cause of virally induced asthma exacerbations, account for much of the burden of asthma in terms of morbidity, mortality, and associated cost. Interleukin-25 (IL-25) activates type 2-driven inflammation and is therefore potentially important in virally induced asthma exacerbations. To investigate this, we examined whether RV-induced IL-25 could contribute to asthma exacerbations. RV-infected cultured asthmatic bronchial epithelial cells exhibited a heightened intrinsic capacity for IL-25 expression, which correlated with donor atopic status. In vivo human IL-25 expression was greater in asthmatics at baseline and during experimental RV infection. In addition, in mice, RV infection induced IL-25 expression and augmented allergen-induced IL-25. Blockade of the IL-25 receptor reduced many RV-induced exacerbation-specific responses including type 2 cytokine expression, mucus production, and recruitment of eosinophils, neutrophils, basophils, and T and non-T type 2 cells. Therefore, asthmatic epithelial cells have an increased intrinsic capacity for expression of a pro-type 2 cytokine in response to a viral infection, and IL-25 is a key mediator of RV-induced exacerbations of pulmonary inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Recent reports suggest a link between IL-25 and viral pathogen-associated asthma exacerbation”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Beale et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global strategy for asthma management and prevention: GINA executive summary
Bateman, E. D., Hurd, S. S., Barnes, P. J., Bousquet, J., Drazen, J. M., FitzGerald, M., Gibson, P., Ohta, K., O'Byrne, P., Pedersen, S. E., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00138707 · Cited by 3,203
Innate lymphoid cells — a proposal for uniform nomenclature
Spits, H., Artis, D., Colonna, M., Diefenbach, A., Di Santo, J. P., Eberl, G., Koyasu, S., Locksley, R. M., McKenzie, A. N. J., Mebius, R. E., et al. (2013) · Nature Reviews Immunology · doi:10.1038/nri3365 · Cited by 2,389
Self-citationPavord, I. D., Korn, S., Howarth, P., Bleecker, E. R., Buhl, R., Keene, O. N., Ortega, H., & Chanez, P. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60988-x · Cited by 2,221
Community study of role of viral infections in exacerbations of asthma in 9–11 year old children
Johnston, S. L., Pattemore, P. K., Sanderson, G., Smith, S., Lampe, F., Josephs, L., Symington, P., Toole, S. O., Myint, S. H., Tyrrell, D. A. J., et al. (1995) · BMJ · doi:10.1136/bmj.310.6989.1225 · Cited by 1,991
Self-citationNuocytes represent a new innate effector leukocyte that mediates type-2 immunity
Neill, D. R., Wong, S. H., Bellosi, A., Flynn, R. J., Daly, M., Langford, T. K. A., Bucks, C., Kane, C. M., Fallon, P. G., Pannell, R., et al. (2010) · Nature · doi:10.1038/nature08900 · Cited by 1,938 · cited 8×
“Althoughwe did not use an exhaustive lineage panel to identify ILC-2 cells, the fact that ICOS is expressed almost exclusively on T cells (particularly TH2) (38–40) and ILC-2 cells meant that we could approximate the number of ILC-2 cells by identifying the CD3−, CD4−, and ICOS+ ST2+ population.”
BackgroundInfluentialSelf-citationT-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma
Woodruff, P. G., Modrek, B., Choy, D. F., Jia, G., Abbas, A. R., Ellwanger, A., Arron, J. R., Koth, L. L., & Fahy, J. V. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0392oc · Cited by 1,803
ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28
Hutloff, A., Dittrich, A. M., Beier, K. C., Eljaschewitsch, B., Kraft, R., Anagnostopoulos, I., & Kroczek, R. A. (1999) · Nature · doi:10.1038/16717 · Cited by 1,482
Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
Wenzel, S., Ford, L., Pearlman, D., Spector, S., Sher, L., Skobieranda, F., Wang, L., Kirkesseli, S., Rocklin, R., Bock, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304048 · Cited by 1,320
Wark, P. A. B., Johnston, S. L., Bucchieri, F., Powell, R., Puddicombe, S., Laza-Stanca, V., Holgate, S. T., & Davies, D. E. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041901 · Cited by 1,235
Self-citationIL-25 Induces IL-4, IL-5, and IL-13 and Th2-Associated Pathologies In Vivo
Fort, M. M., Cheung, J., Yen, D., Li, J., Zurawski, S. M., Lo, S., Menon, S., Clifford, T., Hunte, B., Lesley, R., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00243-6 · Cited by 1,203
Hammad, H., Chieppa, M., Perros, F., Willart, M. A., Germain, R. N., & Lambrecht, B. N. (2009) · Nature Medicine · doi:10.1038/nm.1946 · Cited by 1,139 · cited 1×
“Scienc epithelium is likely to be critical for this interaction because it responds to both allergen (14) and RV infection (15) and has the capacity to produce cytokines that are potent activators of type 2 immunity such as IL-25 (16).”
BackgroundRole of deficient type III interferon-λ production in asthma exacerbations
Contoli, M., Message, S. D., Laza-Stanca, V., Edwards, M. R., Wark, P. A. B., Bartlett, N. W., Kebadze, T., Mallia, P., Stanciu, L. A., Parker, H. L., et al. (2006) · Nature Medicine · doi:10.1038/nm1462 · Cited by 1,006
Self-citationInterleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells
Rincón, M., Anguita, J., Nakamura, T., Fikrig, E., & Flavell, R. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.3.461 · Cited by 810 · cited 1×
“IL-6 has also been associated with type 2 immune responses (26).”
BackgroundT-cell co-stimulation through B7RP-1 and ICOS
Yoshinaga, S. K., Whoriskey, J. S., Khare, S. D., Sarmiento, U., Guo, J., Horan, T., Shih, G., Zhang, M., Coccia, M. A., Kohno, T., et al. (1999) · Nature · doi:10.1038/45582 · Cited by 777
Wang, Y.-H., Angkasekwinai, P., Lu, N., Voo, K. S., Arima, K., Hanabuchi, S., Hippe, A., Corrigan, C. J., Dong, C., Homey, B., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070406 · Cited by 671 · cited 2×
“IL-25 can augment type 2 cytokine production via activation of IL-17RB–expressing immune cells including TH2 cells (20) and type 2 innate lymphoid cells (ILC-2) (23).”
BackgroundTH2, allergy and group 2 innate lymphoid cells
Licona-Limón, P., Kim, L. K., Palm, N. W., & Flavell, R. A. (2013) · Nature Immunology · doi:10.1038/ni.2617 · Cited by 646 · cited 1×
“Scienc epithelium is likely to be critical for this interaction because it responds to both allergen (14) and RV infection (15) and has the capacity to produce cytokines that are potent activators of type 2 immunity such as IL-25 (16).”
BackgroundThe role of T lymphocytes in the pathogenesis of asthma
Larché, M., Robinson, D. S., & Kay, A. B. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.169 · Cited by 572 · cited 1×
“Many studies have detected increased type 2 cells (3, 4) and type 2 cytokines (5, 6) in asthma.”
BackgroundMessage, S. D., Laza-Stanca, V., Mallia, P., Parker, H. L., Zhu, J., Kebadze, T., Contoli, M., Sanderson, G., Kon, O. M., Papi, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804181105 · Cited by 487 · cited 3×
“Mary’s Hospital, London, in accordance with standard guidelines (11).”
BackgroundMethodInfluentialSelf-citationBarlow, J. L., Bellosi, A., Hardman, C. S., Drynan, L. F., Wong, S. H., Cruickshank, J. P., & McKenzie, A. N. J. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.09.041 · Cited by 474
Self-citationMallia, P., Message, S. D., Gielen, V., Contoli, M., Gray, K., Kebadze, T., Aniscenko, J., Laza-Stanca, V., Edwards, M. R., Slater, L., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0833oc · Cited by 415 · cited 1×
“Viruses RV-16 for the human challenge study was obtained from clinical isolates as previously described (11, 44), and RV-1B and RV-16 (American Type Culture Collection) were grown and titrated inHeLa cells (European Collection of Cell Cultures) by standard methods.”
MethodSelf-citationBarlow, J. L., Peel, S., Fox, J., Panova, V., Hardman, C. S., Camelo, A., Bucks, C., Wu, X., Kane, C. M., Neill, D. R., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.05.012 · Cited by 383
Self-citationMouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation
Bartlett, N. W., Walton, R. P., Edwards, M. R., Aniscenko, J., Caramori, G., Zhu, J., Glanville, N., Choy, K. J., Jourdan, P., Burnet, J., et al. (2008) · Nature Medicine · doi:10.1038/nm1713 · Cited by 375
Self-citationBlocking IL-25 prevents airway hyperresponsiveness in allergic asthma
Ballantyne, S. J., Barlow, J. L., Jolin, H. E., Nath, P., Williams, A. S., Chung, K. F., Sturton, G., Wong, S. H., & McKenzie, A. N. J. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.07.051 · Cited by 368 · cited 1×
“Blocking IL-25 in a mouse model of allergic airway disease before allergen sensitization and/or challenge resulted in amarked reduction in allergic inflammation, AHR, and type 2 cytokine (IL-5 and IL-13) production (18).”
BackgroundSelf-citationHuman Rhinovirus Species and Season of Infection Determine Illness Severity
Lee, W.-M., Lemanske, R. F., Evans, M. D., Vang, F., Pappas, T., Gangnon, R., Jackson, D. J., & Gern, J. E. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201202-0330oc · Cited by 310
Self-citationProposals for the classification of human rhinovirus species C into genotypically assigned types
Simmonds, P., McIntyre, C., Savolainen-Kopra, C., Tapparel, C., Mackay, I. M., & Hovi, T. (2010) · Journal of General Virology · doi:10.1099/vir.0.023994-0 · Cited by 275
IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma
Kabesch, M., Schedel, M., Carr, D., Woitsch, B., Fritzsch, C., Weiland, S. K., & von Mutius, E. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.10.024 · Cited by 274 · cited 1×
“Genetic studies have linked numerous type 2–associated genes with asthma [IL-4 (interleukin-4), IL-13, IL-4Ra, and STAT6 (signal transducer and activator of transcription 6)] (7, 8) and asthma exacerbations (IL-4 and IL-4Ra) (9, 10).”
BackgroundIncreased sputum and bronchial biopsy IL-13 expression in severe asthma
Saha, S. K., Berry, M. A., Parker, D., Siddiqui, S., Morgan, A., May, R., Monk, P., Bradding, P., Wardlaw, A. J., Pavord, I. D., et al. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.01.005 · Cited by 255 · cited 1×
“Many studies have detected increased type 2 cells (3, 4) and type 2 cytokines (5, 6) in asthma.”
BackgroundIL-25 enhances allergic airway inflammation by amplifying a TH2 cell–dependent pathway in mice
Tamachi, T., Maezawa, Y., Ikeda, K., Kagami, S.-I., Hatano, M., Seto, Y., Suto, A., Suzuki, K., Watanabe, N., Saito, Y., et al. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.04.051 · Cited by 231 · cited 1×
“Forced expression of IL-25 by transgenic mice has been reported to enhance allergeninduced type 2 responses and pulmonary allergic inflammation (35).”
BackgroundMcIntyre, C. L., Knowles, N. J., & Simmonds, P. (2013) · Journal of General Virology · doi:10.1099/vir.0.053686-0 · Cited by 221 · cited 1×
“Scienc three species (A, B, and C) are now recognized (29).”
BackgroundIL-25 in Atopic Dermatitis: A Possible Link between Inflammation and Skin Barrier Dysfunction?
Hvid, M., Vestergaard, C., Kemp, K., Christensen, G. B., Deleuran, B., & Deleuran, M. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.277 · Cited by 219
Polymorphisms in the IL4 , IL4RA , and FCERIB genes and asthma severity
Sandford, A. J., Chagani, T., Zhu, S., Weir, T. D., Bai, T. R., Spinelli, J. J., FitzGerald, J. M., Behbehani, N. A., Tan, W. C., & Paré, P. D. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.107926 · Cited by 195 · cited 1×
“Genetic studies have linked numerous type 2–associated genes with asthma [IL-4 (interleukin-4), IL-13, IL-4Ra, and STAT6 (signal transducer and activator of transcription 6)] (7, 8) and asthma exacerbations (IL-4 and IL-4Ra) (9, 10).”
BackgroundCorrigan, C. J., Wang, W., Meng, Q., Fang, C., Eid, G., Caballero, M. R., Lv, Z., An, Y., Wang, Y.-H., Liu, Y.-J., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.03.043 · Cited by 189 · cited 1×
“Clinical studies have demonstrated increased IL-25 gene expression togetherwith its receptor, IL-17RB, in tissue from patients with asthma (20) and atopic dermatitis (21), whereas eosinophils, mast cells, and the airway epithelium (17, 22) have been reported as sources within the lung.”
Background(1993) · Thorax · doi:10.1136/thx.48.2_suppl.s1 · Cited by 183
Kaiko, G. E., Phipps, S., Angkasekwinai, P., Dong, C., & Foster, P. S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001758 · Cited by 165 · cited 1×
“Clinical studies have demonstrated increased IL-25 gene expression togetherwith its receptor, IL-17RB, in tissue from patients with asthma (20) and atopic dermatitis (21), whereas eosinophils, mast cells, and the airway epithelium (17, 22) have been reported as sources within the lung.”
BackgroundSputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis
Berry, M. A., Parker, D., Neale, N., Woodman, L. B., Morgan, A. J., Monk, P., Bradding, P. H., Wardlaw, A. J., Pavord, I. D., & Brightling, C. E. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.08.032 · Cited by 155
Viruses in asthma exacerbations
Tan, W. C. (2004) · Current Opinion in Internal Medicine · doi:10.1097/01.mcp.0000146781.11092.0d · Cited by 153 · cited 1×
“Asthmatics are susceptible to more severe viral infections (25), and our model replicated this with increased viral loads detected in mice with allergic airway inflammation (RV-OVA) compared to nonallergic, infected mice (RV-PBS) (Fig.”
BackgroundCollison, A., Hatchwell, L., Verrills, N. M., Wark, P. A. B., de Siqueira, A. P., Tooze, M., Carpenter, H., Don, A. S., Morris, J. C., Zimmermann, N., et al. (2013) · Nature Medicine · doi:10.1038/nm.3049 · Cited by 149 · cited 1×
“Mouse models of allergic asthma exacerbation have also demonstrated the capacity of RV infection to augment TH2 responses and associated features of allergic airway disease such as airway hyperreactivity (AHR) and mucus production (12, 13).”
BackgroundSelf-citationIL4Rα Mutations Are Associated with Asthma Exacerbations and Mast Cell/IgE Expression
Wenzel, S. E., Balzar, S., Ampleford, E., Hawkins, G. A., Busse, W. W., Calhoun, W. J., Castro, M., Chung, K. F., Erzurum, S., Gaston, B., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200607-909oc · Cited by 142 · cited 1×
“Genetic studies have linked numerous type 2–associated genes with asthma [IL-4 (interleukin-4), IL-13, IL-4Ra, and STAT6 (signal transducer and activator of transcription 6)] (7, 8) and asthma exacerbations (IL-4 and IL-4Ra) (9, 10).”
BackgroundTesciuba, A. G., Subudhi, S., Rother, R. P., Faas, S. J., Frantz, A. M., Elliot, D., Weinstock, J., Matis, L. A., Bluestone, J. A., & Sperling, A. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.1996 · Cited by 129
Rhinovirus induces MUC5AC in a human infection model and in vitrovia NF-κB and EGFR pathways
Hewson, C. A., Haas, J. J., Bartlett, N. W., Message, S. D., Laza-Stanca, V., Kebadze, T., Caramori, G., Zhu, J., Edbrooke, M. R., Stanciu, L. A., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00026910 · Cited by 111
Self-citationChristodoulopoulos, P., Cameron, L., Nakamura, Y., Lemière, C., Muro, S., Dugas, M., Boulet, L., Laviolette, M., Olivenstein, R., & Hamid, Q. A. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.114883 · Cited by 108
Defining critical roles for NF‐κB p65 and type I interferon in innate immunity to rhinovirus
Bartlett, N. W., Slater, L. H., Glanville, N., Haas, J., Caramori, G., Casolari, P., Clarke, D. L., Message, S. D., Aniscenko, J., Kebadze, T., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201650 · Cited by 89 · cited 3×
“We have observed that RV-1B infection during allergic airway inflammation augments expression of leukocyte-recruiting chemokines such as CCL5, CCL17, and CCL22 (15).”
BackgroundMethodSelf-citationKaiko, G. E., Loh, Z., Spann, K. M., Lynch, J. P., Lalwani, A., Zheng, Z., Davidson, S., Uematsu, S., Akira, S., Hayball, J. D., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.02.041 · Cited by 70
The Role of IL-15 Deficiency in the Pathogenesis of Virus-Induced Asthma Exacerbations
Laza-Stanca, V., Message, S. D., Edwards, M. R., Parker, H. L., Zdrenghea, M. T., Kebadze, T., Kon, O. M., Mallia, P., Stanciu, L. A., & Johnston, S. L. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002114 · Cited by 69
Self-citationIL-4 Suppresses Dendritic Cell Response to Type I Interferons
Sriram, U., Biswas, C., Behrens, E. M., Dinnall, J.-A., Shivers, D. K., Monestier, M., Argon, Y., & Gallucci, S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.10.6446 · Cited by 50
IL-17E (IL-25) and IL-17RB promote respiratory syncytial virus-induced pulmonary disease
Petersen, B., Dolgachev, V. A., Rasky, A. J., & Lukacs, N. W. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.0913482 · Cited by 47 · cited 2×
“Respiratory syncytial virus (RSV) infection has been shown to induce IL-25 in mouse lungs (24), but most asthma exacerbations are precipitated by RV infections, with only a small minority caused by RSV infections.”
BackgroundPreventing asthma exacerbations: What are the targets?
Botturi, K., Langelot, M., Lair, D., Pipet, A., Pain, M., Chesné, J., Hassoun, D., Lacoeuille, Y., Cavailles, A., & Magnan, A. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.03.010 · Cited by 23
Cited by
Type 2 inflammation in asthma — present in most, absent in many
Fahy, J. V. (2015) · Nature Reviews Immunology · doi:10.1038/nri3786 · Cited by 1,654
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
“Recent reports suggest a link between IL-25 and viral pathogen-associated asthma exacerbation (Beale et al., 2014).”
BackgroundInnate lymphoid cells: A new paradigm in immunology
Eberl, G., Colonna, M., Di Santo, J. P., & McKenzie, A. N. J. (2015) · Science · doi:10.1126/science.aaa6566 · Cited by 878
“ILC2s and IL-13 are also associated with hepatic fibrosis induced in mice by thioacetamide, carbontetrachloride, and Schistosoma mansoni (109), and with pulmonary fibrosis (108), chronic rhinosinusitis (110), and atopic dermatitis (111, 112), as well as allergen- (112, 113) and rhinovirusinduced asthma exacerbation in…”
BackgroundSelf-citationThe cytokine network involved in the host immune response to periodontitis
Pan, W., Wang, Q., & Chen, Q. (2019) · International Journal of Oral Science · doi:10.1038/s41368-019-0064-z · Cited by 696
The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation
Wallrapp, A., Riesenfeld, S. J., Burkett, P. R., Abdulnour, R.-E. E., Nyman, J., Dionne, D., Hofree, M., Cuoco, M. S., Rodman, C., Farouq, D., et al. (2017) · Nature · doi:10.1038/nature24029 · Cited by 638
Metadata
- Authors
- Beale, J., Jayaraman, A., Jackson, D. J., Macintyre, J. D. R., Edwards, M. R., Walton, R. P., Zhu, J., Ching, Y. M., Shamji, B., Edwards, M., Westwick, J., Cousins, D. J., Hwang, Y. Y., McKenzie, A., Johnston, S. L., & Bartlett, N. W.
- Affiliations
- Asthma UK (GB)
- National Health Service (GB)
- Novartis Institutes for Biomedical Research, Horsham W2 1PG, UK.
- King's College London (GB)
- MRC Laboratory of Molecular Biology (GB)
- Corresponding author
- Beale, Janine
- Jayaraman, Annabelle
- Jackson, David J.
- Johnston, Sebastian L.
- Bartlett, Nathan W.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2014-10
- Volume
- 6
- Issue
- 256
- Pages
- 256ra134-256ra134
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC4246061
- OpenAlex
- W2023685287
- Cited by
- 332
- References
- 47
- Citations by year
- 2026: 9 · 2025: 15 · 2024: 15 · 2023: 19 · 2022: 31 · 2021: 30 · 2020: 35 · 2019: 37 · 2018: 27 · 2017: 48 · 2016: 28 · 2015: 30 · 2014: 8
- FWCI
- 25.34
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Occupational exposure and asthma
- Keywords
- rhinovirus, asthma exacerbations, IL-25, Th2 immune response, allergic airway inflammation, viral infection, bronchial epithelial cells, mucus production, eosinophils, basophils, atopy, type 2 cytokines
- MeSH terms
- Asthma, Cells, Cultured, Humans, Hypersensitivity, Picornaviridae Infections, Pneumonia, Viral, Rhinovirus, T-Lymphocytes, Interleukin-17, Receptors, Interleukin-17
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.